132 related articles for article (PubMed ID: 37218479)
1. Obesity, Charlson comorbidity index, and neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: relationship to disease severity.
Uzunlar EA; Yildiran H; Kokturk N; Kilic H; Hasanoglu HC
Bratisl Lek Listy; 2023; 124(7):520-526. PubMed ID: 37218479
[TBL] [Abstract][Full Text] [Related]
2. The Neutrophil to Lymphocyte Ratio Is Related to Disease Severity and Exacerbation in Patients with Chronic Obstructive Pulmonary Disease.
Furutate R; Ishii T; Motegi T; Hattori K; Kusunoki Y; Gemma A; Kida K
Intern Med; 2016; 55(3):223-9. PubMed ID: 26831014
[TBL] [Abstract][Full Text] [Related]
3. The relationship between fear of movement, pain and fatigue severity, dyspnea level and comorbidities in patients with chronic obstructive pulmonary disease.
Vardar-Yagli N; Calik-Kutukcu E; Saglam M; Inal-Ince D; Arikan H; Coplu L
Disabil Rehabil; 2019 Sep; 41(18):2159-2163. PubMed ID: 29631469
[No Abstract] [Full Text] [Related]
4. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients.
Sakurai K; Chubachi S; Irie H; Tsutsumi A; Kameyama N; Kamatani T; Koh H; Terashima T; Nakamura H; Asano K; Betsuyaku T
BMC Pulm Med; 2018 May; 18(1):65. PubMed ID: 29720140
[TBL] [Abstract][Full Text] [Related]
6. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
[TBL] [Abstract][Full Text] [Related]
7. The effect of obesity on dyspnea, exercise capacity, walk work and workload in patients with COPD.
Şahin H; Naz İ; Varol Y; Kömürcüoğlu B
Tuberk Toraks; 2017 Sep; 65(3):202-209. PubMed ID: 29135398
[TBL] [Abstract][Full Text] [Related]
8. The peripheral neutrophils in subjects with COPD-OSA overlap syndrome and severe comorbidities: A feasible inflammatory biomarker?
Macrea M; Campbell S; Martin T; Oursler KA
Adv Clin Exp Med; 2018 Dec; 27(12):1677-1682. PubMed ID: 30085419
[TBL] [Abstract][Full Text] [Related]
9. Suppressor of variegation 3-9 homologue 1 impairment and neutrophil-skewed systemic inflammation are associated with comorbidities in COPD.
Chen TT; Wu SM; Chen KY; Tseng CH; Ho SC; Chuang HC; Feng PH; Liu WT; Han CL; Huang EW; Yeh YK; Lee KY
BMC Pulm Med; 2021 Oct; 21(1):276. PubMed ID: 34598691
[TBL] [Abstract][Full Text] [Related]
10. Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients.
Lim JU; Lee JH; Kim JS; Hwang YI; Kim TH; Lim SY; Yoo KH; Jung KS; Kim YK; Rhee CK
Int J Chron Obstruct Pulmon Dis; 2017; 12():2465-2475. PubMed ID: 28860741
[TBL] [Abstract][Full Text] [Related]
11. [The associations between comorbidity and exacerbation risk in patients with chronic obstructive pulmonary disease].
Huang YL; Mao B; Mim J; Li GH; Zheng YQ; Wu LH; Wang SJ; Qu B; Fu JJ
Zhonghua Jie He He Hu Xi Za Zhi; 2018 May; 41(5):349-354. PubMed ID: 29747278
[No Abstract] [Full Text] [Related]
12. «OBESITY PARADOX» IN COMORBID STABLE ISCHEMIC HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS.
Nemish IL; Stupnytska GY; Fediv OI
Wiad Lek; 2021; 74(2):278-281. PubMed ID: 33813486
[TBL] [Abstract][Full Text] [Related]
13. Correlatıon of neutrophyle/lymphocyte ratio and pulmonary parameters with optic coherence tomography findings in stable chronic obstructive pulmonary disease.
Ozer PA; Ogan N
Clin Respir J; 2020 Apr; 14(4):353-363. PubMed ID: 31883195
[TBL] [Abstract][Full Text] [Related]
14. "Obesity paradox" in chronic obstructive pulmonary disease.
Blum A; Simsolo C; Sirchan R; Haiek S
Isr Med Assoc J; 2011 Nov; 13(11):672-5. PubMed ID: 22279700
[TBL] [Abstract][Full Text] [Related]
15. Obesity in COPD: Comorbidities with Practical Consequences?
Zewari S; Hadi L; van den Elshout F; Dekhuijzen R; Heijdra Y; Vos P
COPD; 2018 Oct; 15(5):464-471. PubMed ID: 30512982
[TBL] [Abstract][Full Text] [Related]
16. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
17. Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review.
Pascual-González Y; López-Sánchez M; Dorca J; Santos S
Int J Chron Obstruct Pulmon Dis; 2018; 13():3651-3662. PubMed ID: 30464448
[TBL] [Abstract][Full Text] [Related]
18. Are Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios Prognostic Indicators in Patients With Chronic Obstructive Pulmonary Disease in Intensive Care Units?
Eraslan Doganay G; Cirik MO
Cureus; 2022 Mar; 14(3):e23499. PubMed ID: 35494932
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study.
Lee SJ; Lee HR; Lee TW; Ju S; Lim S; Go SI; You JW; Cho YJ; Lee GW; Jeong YY; Kim HC; Lee JD
Korean J Intern Med; 2016 Sep; 31(5):891-8. PubMed ID: 27017385
[TBL] [Abstract][Full Text] [Related]
20. Gender and respiratory factors associated with dyspnea in chronic obstructive pulmonary disease.
de Torres JP; Casanova C; Montejo de Garcini A; Aguirre-Jaime A; Celli BR
Respir Res; 2007 Mar; 8(1):18. PubMed ID: 17341300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]